Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
BioMarin Pharmaceutical Inc. Stock Price (Quote) NASDAQ:BMRN
$73.74 ( -1.78% ) Friday, 22nd Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $73.10 | $79.98 | Friday, 22nd Oct 2021 BMRN stock ended at $73.74. This is 1.78% less than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 2.08% from a day low at $73.28 to a day high of $74.80. |
| 90 days | $73.10 | $85.28 | |
| 52 weeks | $71.65 | $92.57 |
Historical BioMarin Pharmaceutical Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-22 | $74.80 | $74.80 | $73.28 | $73.74 | 1 018 594 |
| 2021-10-21 | $75.27 | $75.86 | $74.97 | $75.08 | 703 224 |
| 2021-10-20 | $74.60 | $75.89 | $74.42 | $75.15 | 1 061 718 |
| 2021-10-19 | $74.40 | $75.50 | $73.92 | $74.14 | 1 505 161 |
| 2021-10-18 | $75.75 | $75.81 | $73.10 | $73.92 | 1 688 695 |
| 2021-10-15 | $77.52 | $77.99 | $75.87 | $75.89 | 1 516 829 |
| 2021-10-14 | $76.87 | $78.37 | $76.06 | $77.52 | 1 672 010 |
| 2021-10-13 | $78.77 | $79.42 | $76.68 | $76.82 | 1 353 614 |
| 2021-10-12 | $78.04 | $79.37 | $77.96 | $78.63 | 1 413 991 |
| 2021-10-11 | $77.71 | $79.32 | $77.56 | $77.90 | 797 848 |
| 2021-10-08 | $77.49 | $78.48 | $76.88 | $77.83 | 1 154 892 |
| 2021-10-07 | $78.77 | $79.49 | $76.97 | $77.14 | 902 747 |
| 2021-10-06 | $76.46 | $78.71 | $76.46 | $77.87 | 1 010 972 |
| 2021-10-05 | $75.98 | $76.94 | $75.96 | $76.73 | 641 728 |
| 2021-10-04 | $76.00 | $77.03 | $75.19 | $75.88 | 962 677 |
| 2021-10-01 | $77.18 | $77.74 | $76.13 | $77.16 | 1 029 434 |
| 2021-09-30 | $77.03 | $77.86 | $76.80 | $77.29 | 1 450 870 |
| 2021-09-29 | $76.84 | $78.01 | $76.72 | $76.79 | 893 102 |
| 2021-09-28 | $78.00 | $78.55 | $77.09 | $77.18 | 803 165 |
| 2021-09-27 | $78.88 | $79.58 | $78.00 | $78.62 | 796 683 |
| 2021-09-24 | $79.10 | $79.41 | $78.34 | $78.60 | 463 136 |
| 2021-09-23 | $79.29 | $79.98 | $78.88 | $79.30 | 702 146 |
| 2021-09-22 | $78.61 | $79.63 | $77.42 | $79.03 | 1 061 928 |
| 2021-09-21 | $77.16 | $78.87 | $77.16 | $78.15 | 1 177 222 |
| 2021-09-20 | $77.26 | $78.69 | $76.84 | $77.38 | 1 060 620 |
| 2021-09-17 | $76.42 | $77.98 | $76.40 | $77.76 | 3 064 336 |
| 2021-09-16 | $76.66 | $77.30 | $75.82 | $76.50 | 795 384 |
| 2021-09-15 | $76.90 | $77.44 | $76.00 | $77.27 | 1 238 494 |
| 2021-09-14 | $78.50 | $78.69 | $76.10 | $76.17 | 791 027 |
| 2021-09-13 | $78.21 | $78.78 | $77.67 | $77.98 | 1 372 442 |
| 2021-09-10 | $80.64 | $81.17 | $77.93 | $77.98 | 1 318 564 |
| 2021-09-09 | $78.61 | $80.58 | $77.73 | $80.11 | 2 130 231 |
| 2021-09-08 | $77.71 | $78.27 | $76.57 | $76.70 | 1 522 864 |
| 2021-09-07 | $78.01 | $81.92 | $77.60 | $77.81 | 2 484 399 |
| 2021-09-03 | $85.15 | $85.24 | $84.36 | $84.95 | 1 031 298 |
| 2021-09-02 | $84.14 | $85.24 | $83.33 | $85.15 | 994 193 |
| 2021-09-01 | $84.52 | $85.28 | $83.69 | $84.27 | 840 040 |
| 2021-08-31 | $82.48 | $84.50 | $82.25 | $84.21 | 1 478 224 |
| 2021-08-30 | $83.76 | $85.01 | $83.06 | $83.27 | 1 598 992 |
| 2021-08-27 | $79.13 | $84.23 | $79.10 | $83.51 | 2 127 065 |
| 2021-08-26 | $78.85 | $79.41 | $78.13 | $78.82 | 1 004 339 |
| 2021-08-25 | $77.06 | $78.67 | $76.82 | $78.52 | 922 169 |
| 2021-08-24 | $75.41 | $77.29 | $75.20 | $77.24 | 1 239 919 |
| 2021-08-23 | $75.45 | $75.70 | $75.16 | $75.47 | 880 587 |
| 2021-08-20 | $74.86 | $75.54 | $74.65 | $75.14 | 1 238 735 |
| 2021-08-19 | $75.51 | $76.74 | $74.68 | $74.77 | 1 155 865 |
| 2021-08-18 | $76.58 | $76.67 | $75.34 | $75.54 | 726 320 |
| 2021-08-17 | $74.79 | $76.53 | $74.60 | $76.36 | 911 188 |
| 2021-08-16 | $74.73 | $75.42 | $73.95 | $75.10 | 835 952 |
| 2021-08-13 | $75.71 | $76.23 | $74.95 | $75.03 | 925 981 |
BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of MPS IV A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with mucopolysaccharidosis VI; Kuvan, a proprietary syn... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
